Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles
Background/Aims: This study investigated the underlying mechanisms of the antidepressant effects of curcumin and dexanabinol-loaded solid lipid nanoparticles in corticosterone-induced cell and mice depression models. Methods: Curcumin and dexanabinol-loaded solid lipid nanoparticles (Cur/SLNs-HU-211...
Main Authors: | Xiaolie He, Li Yang, Mei Wang, Xizhen Zhuang, Ruiqi Huang, Rongrong Zhu, Shilong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-08-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/480001 |
Similar Items
-
Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder
by: Xiao-Lie He, et al.
Published: (2021-01-01) -
Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice
by: Eduardo A. V. Marinho, et al.
Published: (2023-02-01) -
Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023-08-01) -
Maternal sevoflurane exposure induces neurotoxicity in offspring rats via the CB1R/CDK5/p-tau pathway
by: Yuxiao Wan, et al.
Published: (2023-01-01) -
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
by: Adriano Mollica, et al.
Published: (2017-01-01)